Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell Carcinoma

Oncocytic (Hürthle cell) carcinoma of the thyroid (HCC) is genetically characterized by complex I mitochondrial DNA mutations and widespread chromosomal losses. Here, we utilize RNA sequencing and metabolomics to identify candidate molecular effectors activated by these genetic drivers. We find glut...

Descripción completa

Detalles Bibliográficos
Autores principales: Gopal, Raj K., Vantaku, Venkata R., Panda, Apekshya, Reimer, Bryn, Rath, Sneha, To, Tsz-Leung, Fisch, Adam S., Cetinbas, Murat, Livneh, Maia, Calcaterra, Michael J., Gigliotti, Benjamin J., Pierce, Kerry A., Clish, Clary B., Dias-Santagata, Dora, Sadow, Peter M., Wirth, Lori J., Daniels, Gilbert H., Sadreyev, Ruslan I., Calvo, Sarah E., Parangi, Sareh, Mootha, Vamsi K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401073/
https://www.ncbi.nlm.nih.gov/pubmed/37262067
http://dx.doi.org/10.1158/2159-8290.CD-22-0976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401073/
https://www.ncbi.nlm.nih.gov/pubmed/37262067
http://dx.doi.org/10.1158/2159-8290.CD-22-0976

Ejemplares similares